Imagen Network Fuses Gemini and xAI Tech to Elevate Personalization at Scale 
Metavista3D Unveils AI-Powered 3D E-Mirror at the AutoTech Science Fair in Palo Alto 
ExcelMindCyber Institute Launches Program Enabling Business Professionals to Lead Security Assessments 
Stardust Solar Energy Inc. Announces Annual Meeting Results/Shareholder Approval of New By-Law No. 1 with Advance Notice Provisions 
NFPA Codes Tighten Regulations on DAS: TX RX Systems Responds with an Emergency Power Off Solution Immunocore to present at the SVB Leerink Global Healthcare Conference
Immunocore to present at the SVB Leerink Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn….
Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial Results
Company prioritizing industry-leading clinical-stage programs, AXO-AAV-GM1 and AXO-AAV-GM2, the first potential disease-modifying therapies for GM1…
IsoPlexis to Participate in Three Upcoming Investor Conferences
BRANFORD, Conn., Feb. 11, 2022 (GLOBE NEWSWIRE) — IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell…
Talaris Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
BOSTON and LOUISVILLE, Ky., Feb. 11, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS),…
Newell Brands Announces Fourth Quarter and Full Year 2021 Results
Q4 Net Sales Growth 4.3%; Core Sales Growth 5.8% Q4 Diluted EPS $0.22; Normalized Diluted…
Cleveland-Cliffs Reports Full-Year and Fourth-Quarter 2021 Results and Announces $1 Billion Share Repurchase Program
Record annual revenue of $20.4 billion Record annual net income of $3.0 billion Record annual…
Danimer Scientific Announces Date for Fourth Quarter and Full Year 2021 Results
BAINBRIDGE, Ga.–(BUSINESS WIRE)–Danimer Scientific (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics…
Syniverse to Pursue Alternative Transaction with Twilio Following Termination of Business Combination Agreement with M3-Brigade Acquisition II Corp.
TAMPA, Fla.–(BUSINESS WIRE)–Syniverse®, the “world’s most connected company®” and a premier global technology provider of…
New Data Presented at ISC 2022 Further Validates Impact of the Viz Platform for Intelligent Care Coordination in the Real World
SAN FRANCISCO & NEW ORLEANS–(BUSINESS WIRE)–#AI–Data from several new studies presented this week at the…
IAA, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results
Delivers Record 2021 Results Introduces Full-Year 2022 Outlook WESTCHESTER, Ill.–(BUSINESS WIRE)–IAA, Inc. (NYSE: IAA) today…
The Arena Group Announces Pricing of $30,000,000 Public Offering, Following February 9, 2022 Uplisting to the NYSE American
NEW YORK–(BUSINESS WIRE)–The Arena Group Holdings, Inc., formerly known as theMaven, Inc. (NYSEAMERICAN: AREN) (the…
Protolabs Reports Financial Results for the Fourth Quarter and Full Year 2021
Revenue of $123.6 million in the Fourth Quarter of 2021, an increase of 18% year-over-year…
Invitation to Novozymes’ annual shareholders’ meeting 2022
Please read the invitation in PDF Attachment Invitation to Novozymes’ Annual Shareholders’ Meeting 2022
Great News for Job seekers, Recruitment Agencies & Employers: World’s First Blockchain-Certied AI-matched – Trusted NFT Resume Marketplace is here
Tallinn, Estonia–(Newsfile Corp. – February 11, 2022) – TrustRecruit presents the world’s first AI-enabled verified…
New two-year data for Roche’s Vabysmo and Susvimo reinforce potential to maintain vision with fewer treatments for people with two leading causes of vision loss
In the YOSEMITE and RHINE studies in diabetic macular edema, at least 60% of eligible…
Nykode Therapeutics announces completion of patient enrollment in its Phase 2 trial of VB10.16 in combination with atezolizumab for the treatment of advanced cervical cancer
Nykode Therapeutics has reached the enrollment target of 50 patients in its VB C-02 trial…
Genocea to Present at the 11th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical…
Facedrive Provides Update on Facedrive Foods’ Revenue and Expenses
TORONTO–(BUSINESS WIRE)–#FacedriveScarborough–Facedrive Inc. (“Facedrive” or the “Company”) (TSXV:FD), (OTC:FDVRF), a Canadian “people-and-planet first” tech ecosystem…
Twist Bioscience Announces Pricing of an Upsized $250 Million Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed…
IN8bio to present at Bio CEO & Investor Conference and Next Generation CAR-TCR Summit
NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta…